AMNOG
The Arzneimittelmarkt-Neuordnungsgesetz (AMNOG, English translation: "Pharmaceuticals Market Reorganisation Act") is a German law relating to the marketing of pharmaceutical products in Germany. It requires drug manufacturers to submit evidence to the Federal Joint Committee (Germany) to show that their new products are more effective than previous products. It is credited with reducing the cost of healthcare in Germany.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
AMNOG
The Arzneimittelmarkt-Neuordnungsgesetz (AMNOG, English translation: "Pharmaceuticals Market Reorganisation Act") is a German law relating to the marketing of pharmaceutical products in Germany. It requires drug manufacturers to submit evidence to the Federal Joint Committee (Germany) to show that their new products are more effective than previous products. It is credited with reducing the cost of healthcare in Germany.
has abstract
The Arzneimittelmarkt-Neuordnu ...... cost of healthcare in Germany.
@en
Wikipage page ID
42,876,812
page length (characters) of wiki page
Wikipage revision ID
944,383,226
Link from a Wikipage to another Wikipage
wikiPageUsesTemplate
hypernym
type
comment
The Arzneimittelmarkt-Neuordnu ...... cost of healthcare in Germany.
@en
label
AMNOG
@en